Lumicera Health Services, Navitus’ specialty pharmacy, has made a deal with Teva to offer an unbranded biosimilar that they estimate will save $112,000 and $336,000 per patient per year. Navitus will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback